human
cytomegaloviru
hcmv
widespread
human
seropreval
close
relat
socioeconom
geograph
condit
lifelong
latent
persist
hcmv
infect
establish
immunocompet
popul
primari
infect
product
replic
occur
spontan
reactiv
due
immun
abnorm
thu
hcmv
major
viral
caus
mental
retard
sensorineur
deaf
newborn
particularli
caus
morbid
mortal
transplant
recipi
aid
patient
immunocompromis
state
current
studi
also
tie
hcmv
multipl
common
chronic
inflammatori
diseas
cardiovascular
diseas
autoimmun
diseas
inflammatori
bowel
diseas
ibd
certain
cancer
hcmv
larg
linear
dsdna
genom
size
encod
open
read
frame
orf
matur
mirna
encod
premirna
larg
size
viral
genom
enabl
coevolut
host
million
year
acquir
variou
even
redund
strategi
immun
evas
establish
lifelong
latent
persist
infect
result
special
balanc
immun
microenviron
hcmv
interplay
viral
reactiv
immun
respons
establish
intens
research
mechan
could
potenti
contribut
better
understand
pathogenesi
biolog
viru
sinc
key
immun
cell
nk
b
cell
product
infect
hcmv
previou
studi
mainli
focus
infect
permiss
myeloid
lineag
stromal
cell
alter
abil
cell
prime
activ
nk
natur
killer
cell
cell
downmodul
mhc
major
histocompat
complex
costimulatori
molecul
suppress
activ
signal
provis
inhibitori
molecul
fact
hcmv
also
use
divers
tactic
modul
earli
immun
respons
type
interferon
ifn
proinflammatori
cytokin
rapidli
express
secret
infect
cell
upon
detect
hcmv
bind
entri
gene
express
profil
assay
reveal
larg
number
antivir
gene
belong
interferon
stimul
gene
isg
famili
inflammatori
cytokin
famili
strongli
induc
earli
event
hcmv
entri
bind
cellular
receptor
hcmv
envelopeglycoprotein
initi
signal
transduct
pathway
lead
activ
interferon
regulatori
factor
particip
subsequ
transcript
antivir
type
ifn
proinflammatori
cytokin
earli
immun
respons
pivot
time
host
defend
hcmv
infect
recombin
therapeut
use
control
hcmvinduc
retin
patient
aid
congenit
viremia
hcmv
infect
hcmv
protein
shown
target
earli
antivir
immun
respons
exampl
encod
hcmv
immediateearli
gene
effici
suppress
hcmv
sendai
viru
sev
induc
express
hcmv
tegument
protein
report
inhibit
stimul
interferon
gene
sting
mediat
signal
evad
antivir
innat
immun
cellular
receptor
mediat
signal
pathway
gener
assum
play
import
role
earliest
immun
respons
viru
infect
previou
studi
tolllik
receptor
report
critic
earli
respons
hcmv
infect
recogn
viral
surfac
glycoprotein
gb
gh
typei
transmembran
glycoprotein
immunoglobulin
superfamili
found
confirm
play
import
role
hcmvtrigger
earli
antivir
signal
first
time
interestingli
also
found
express
downregul
late
stage
hcmv
infect
target
gene
hcmvencod
simultan
express
secret
cyclophilin
scypa
report
ligand
upregul
respons
hcmv
infect
multifunct
transmembran
glycoprotein
involv
neural
function
proinflamm
tumor
invas
metastasi
extracellular
cypa
report
induc
product
proinflammatori
cytokin
direct
bind
ectodomain
seen
previou
work
specif
biolog
signific
mechan
hcmv
target
earli
antivir
respons
hcmv
infect
investig
discuss
studi
human
foreskin
fibroblast
hff
cell
passag
human
astrocytoma
cell
cell
human
embryon
kidney
cell
cell
maintain
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
previous
describ
herp
simplex
viru
provid
fenyong
liu
univers
california
berkeley
ca
usa
gener
overexpress
cell
line
mg
cell
transfect
plasmid
invitrogen
carlsbad
ca
usa
empti
vector
control
plasmid
use
lipofectaminetm
prescrib
manufactur
life
technolog
waltham
usa
incub
transfect
cell
select
resist
cell
cultur
medium
contain
life
technolog
two
three
week
select
singl
clone
randomli
isol
plate
separ
level
individu
select
clone
determin
western
blot
analysi
mainten
medium
cell
line
supplement
bacteri
artifici
chromosom
bac
deriv
clinic
strain
enhanc
green
fluoresc
protein
egfp
express
cassett
provid
dr
ke
zen
nanj
univers
nanj
china
use
studi
hcmv
mutant
revert
wild
type
rvwt
gener
use
bacteri
recombin
method
previous
describ
brief
approxim
bp
flank
region
clone
vector
three
nucleotid
seed
region
mutat
use
sitedirect
polymeras
chain
reaction
pcr
pcramplifi
product
contain
point
mutat
use
second
round
recombin
replac
tetstr
cassett
insert
region
first
amplifi
dna
fragment
transform
e
coli
cell
electropor
biorad
hercul
ca
usa
bacteria
harbor
rescu
bac
select
presenc
streptomycin
mutant
confirm
use
bac
dna
sequenc
similarli
bac
rvwt
gener
base
newli
construct
two
round
recombin
hcmv
wt
rvwt
propag
hff
cell
viru
stock
store
dmem
supplement
fetal
bovin
serum
fb
bovin
serum
albumin
bsa
cyclosporin
csa
reagent
obtain
sigmaaldrich
st
loui
mo
usa
antibodi
hab
prepar
laboratori
dylight
secondari
antibodi
use
immunofluoresc
life
technolog
san
jose
ca
usa
also
use
antihcmv
mous
mab
abcam
cambridg
uk
rabbit
antihuman
cypa
mab
abcam
rabbit
mab
cell
signal
technolog
cst
danver
usa
rabbit
mab
cst
rabbit
mab
cst
rabbit
mab
cst
rabbit
mab
cst
rabbit
mab
cst
antigapdh
mous
mab
proteintech
rosemont
il
usa
follow
plasmid
use
lentivir
shrna
nontarget
shrna
control
plasmid
purchas
open
biosystem
ge
healthcar
littl
chalfont
uk
hcmvencod
lentivir
shrna
construct
studi
empti
vector
obtain
invitrogen
carlsbad
ca
usa
fulllength
plasmid
construct
laboratori
extracellular
domain
residu
intracellular
domain
residu
delet
gener
respect
promot
report
plasmid
promot
report
plasmid
obtain
beyotim
shanghai
china
dual
luciferas
mirna
target
express
vector
pmirglo
renilla
luciferas
control
report
plasmid
prltk
purchas
promega
madison
wi
usa
plasmid
made
insert
utr
human
gene
pmirglo
empti
vector
use
primer
follow
forward
revers
sitedirect
mutagenesi
perform
use
quikchang
lightn
multi
sitedirect
mutagenesi
kit
stratagen
san
diego
ca
usa
gener
plasmid
follow
primer
forward
revers
cell
grown
chamber
cover
slip
infect
hcmv
strain
multipl
infect
moi
h
posttransfect
cell
fix
formaldehyd
block
bovin
serum
albumin
bsa
pb
stain
primari
mous
antibodi
abcam
cambridg
uk
incub
secondari
antibodi
dylight
antimous
igg
life
technolog
cell
nucleu
stain
dapi
invitrogen
imag
captur
nikon
eclips
microscop
diagnost
instrument
inc
sterl
height
mi
usa
digit
imag
subsequ
merg
use
asw
softwar
olympu
tokyo
japan
cell
cotransfect
two
packag
plasmid
togeth
control
rnai
lentivir
plasmid
use
lipofectaminetm
invitrogen
sequenc
shrna
sequenc
shrna
h
cell
incub
fresh
medium
without
antibiot
anoth
h
medium
contain
recombin
viru
collect
filter
ad
hff
cell
presenc
mgml
polybren
infect
cell
select
ad
puromycin
mgml
cultur
medium
day
addit
experi
silenc
express
verifi
qpcr
western
blot
cell
seed
plate
follow
day
transfect
use
lipofectaminetm
invitrogen
indic
plasmid
transfect
effici
normal
renilla
luciferas
report
plasmid
prltk
ad
transfect
total
amount
transfec
dna
maintain
consist
level
ad
empti
vector
dna
posttransfect
cell
lyse
passiv
lysi
buffer
promega
supernat
clarifi
centrifug
use
perform
luciferas
assay
use
dual
luciferas
assay
kit
promega
valu
firefli
luciferas
activ
normal
renilla
luciferas
activ
report
assay
repeat
least
three
time
triplic
data
shown
averag
valu
standard
deviat
sd
one
repres
experi
viral
dna
extract
mock
hcmvinfect
cell
use
dneasi
tissu
kit
qiagen
hilden
germani
intracellular
viral
dna
quantifi
use
primer
probe
amplifi
hcmv
dna
region
previous
describ
reaction
perform
amplif
mixtur
dna
extract
premix
ex
taqtm
takara
dalian
china
primer
fluorogen
probe
rox
refer
dye
ii
use
abi
devic
appli
biosystem
inc
foster
citi
ca
usa
pcr
cycl
condit
follow
cycl
viral
genom
copi
normal
cellular
rnase
p
theprevi
describ
primer
probe
unknown
sampl
valu
determin
standard
curv
known
copi
number
bac
rnase
p
set
assay
repeat
three
time
triplic
data
shown
averag
valu
sd
one
repres
experi
total
rna
isol
trizol
reagent
invitrogen
cdna
revers
transcrib
use
primescripttm
rt
reagent
kit
takara
sybrgreen
realtim
pcr
rtpcr
perform
abi
devic
appli
biosystem
inc
use
sybr
premix
ex
taq
ii
takara
cellular
gapdh
dehydrogenas
use
normal
rna
input
rel
chang
gene
express
analyz
use
method
primer
synthes
shanghai
genepharma
co
ltd
list
follow
forward
revers
cyclophilin
forward
revers
forward
revers
forward
revers
forward
revers
forward
revers
gapdh
forward
revers
chemic
synthet
sirna
target
mrna
cd
region
hcmv
mirbas
mirbas
screen
hcmvencod
matur
microrna
http
wwwmirbaseorg
synthes
ribobio
co
ltd
guangzhou
china
along
silenc
neg
control
sirna
csirna
molecul
sirna
transfect
cell
use
lipofectaminetm
invitrogen
accord
manufactur
instruct
cell
wash
cold
pb
lyse
ml
lysi
buffer
mm
proteas
inhibitor
cocktail
roch
basel
switzerland
min
ice
cell
lysat
centrifug
rpm
min
supernat
collect
protein
concentr
determin
bca
assay
protein
separ
sdspolyacrylamid
gel
electrophoresi
transfer
polyvinyliden
fluorid
pvdf
membran
ge
healthcar
block
bsa
perform
h
tb
triton
tbst
follow
incub
primari
antibodi
solut
overnight
membran
rins
time
min
tbst
rins
membran
incub
hors
radish
peroxidas
hrp
conjug
secondari
antibodi
solut
h
room
temperatur
anoth
rins
membran
subsequ
react
chemiluminesc
substrat
accord
recommend
ecl
western
blot
detect
reagent
kit
thermo
scientif
waltham
usa
quantit
chemiluminesc
signal
use
ccd
camerabas
imag
biorad
hercul
ca
usa
quantit
perform
linear
rang
protein
detect
analyz
imag
lab
softwar
biorad
experi
repeat
least
three
time
triplic
repres
result
shown
cell
either
mock
hcmv
infect
moi
ml
dmem
fetal
bovin
serum
medium
replac
fetal
bovin
serum
contain
dmem
h
incub
protein
extract
prepar
infect
cell
day
postinfect
analyz
western
blot
analysi
determin
viral
growth
level
cell
infect
hcmv
moi
viral
stock
prepar
total
cell
medium
harvest
day
postinfect
ad
equal
volum
wv
skim
milk
follow
ultrason
titer
viral
stock
determin
hff
cell
standard
viru
plaqu
assay
number
plaqu
count
day
viral
infect
valu
obtain
averag
sd
triplic
experi
statist
analys
perform
graphpad
prism
version
graphpad
softwar
san
diego
ca
usa
experi
repeat
least
three
time
triplic
data
express
mean
standard
deviat
mean
two
group
compar
use
unpair
ttest
oneway
analysi
varianc
anova
post
hoc
bonferroni
ttest
differ
consid
statist
signific
p
mani
transmembran
receptor
protein
propos
mediat
signal
transduct
pathway
activ
earli
antivir
immun
hcmv
entri
investig
role
respons
establish
two
stabl
knockdown
short
hairpin
rna
target
utr
cellular
mrna
two
correspond
nonspecif
rnai
stabl
cell
control
sicontrol
via
lentiviralbas
transduct
human
astrocytoma
cell
cell
human
foreskin
fibroblast
cell
hff
cell
express
markedli
reduc
cell
compar
level
sicontrol
cell
observ
immunoblot
figur
measur
effect
knockdown
hcmvinduc
activ
promot
use
dualluciferas
report
assay
cell
knockdown
significantli
reduc
activ
promot
stimul
infect
hcmv
herp
simplex
viru
figur
addit
ectop
express
extracellular
domain
residu
intracellular
domain
residu
delet
mutant
restor
promot
activ
impair
rnai
result
confirm
specif
contribut
induct
hcmv
infect
figur
next
examin
whether
endogen
requir
hcmvinduc
antivir
signal
physiolog
condit
found
knockdown
express
hff
cell
decreas
activ
interferonstimul
gene
express
induc
hcmv
infect
well
express
downstream
gene
figur
togeth
data
suggest
might
block
hcmvtrigger
earli
antivir
immun
respons
virusspecif
manner
result
one
might
assum
act
receptor
hcmv
infect
howev
signific
effect
hcmv
entri
either
test
functionblock
antibodi
inhibit
hcmv
infect
hff
cell
express
knock
cell
figur
previou
report
agre
well
find
studi
found
cypa
bind
directli
ectodomain
could
therefor
respons
proinflammatori
effect
thu
reason
specul
hcmv
infect
might
promot
express
releas
cellular
cypa
could
lead
activ
innat
immun
signal
interact
test
hypothesi
analyz
kinet
cypa
rna
express
quantit
realtim
pcr
intracellular
cypa
incypa
secret
cypa
scypa
protein
level
western
blot
analysi
follow
hcmv
infect
hff
cell
shown
figur
rel
mrna
level
cypa
rna
express
gradual
upregul
hcmv
infect
addit
incypa
scypa
highli
express
postinfect
hpi
follow
gradual
increas
express
level
prolong
hcmv
infect
figur
previou
studi
cypa
demonstr
activ
pathway
interact
promot
inflammatori
effect
monocyt
macrophag
transcript
factor
play
key
role
induct
cellular
antivir
respons
phosphoryl
requir
activ
constitut
key
checkpoint
thu
next
determin
whether
hcmvtrigger
antivir
signal
activ
erk
hff
cell
shown
figur
phosphoryl
level
subunit
increas
respons
hcmv
infect
compar
mock
infect
medium
howev
endogen
express
knock
lentiviralbas
transduct
short
hairpin
rna
hcmvinduc
phosphoryl
level
dramat
reduc
rel
sicontrol
group
decreas
activ
phosphoryl
obviou
level
potenti
emphas
import
lead
role
erk
activ
signal
transduct
furthermor
mab
cyclosporin
csa
novel
inhibitor
cypa
specif
block
direct
bind
cypa
also
inhibit
hcmvinduc
phosphoryl
figur
togeth
result
suggest
hcmv
infect
trigger
secret
cypa
activ
phosphoryl
erk
downstream
interact
ultim
promot
cellular
antivir
signal
pathway
due
potenti
role
may
play
hcmv
earli
antivir
signal
mention
next
investig
influenc
hcmv
infect
express
kinet
cellular
differ
phase
hcmv
replic
cycl
protein
express
level
dramat
downregul
hpi
hcmv
infect
figur
correspond
decreas
rel
rna
express
figur
well
known
microrna
encod
hcmv
play
essenti
role
aspect
hcmv
life
cycl
manipul
mani
cellular
signal
pathway
thu
next
investig
whether
express
target
downregul
one
hcmvencod
matur
mirna
previous
identifi
reactom
databas
wwwreactomeorg
use
rnahybrid
http
bibiservtechfakunibielefelddernahybridsubmiss
screen
hcmvencod
matur
mirna
candid
might
target
utr
region
experiment
determin
hcmvencod
mirna
target
pmirglo
dual
luciferas
report
plasmid
contain
utr
sequenc
human
downstream
firefli
luciferas
gene
gener
transfect
human
embryon
kidney
cell
cell
individu
put
hcmv
mirna
construct
subsequ
luciferas
assay
suggest
like
target
figur
like
target
site
identifi
rnahybrid
utr
region
mrna
figur
next
perform
sitedirect
mutagenesi
seed
sequenc
predict
target
site
report
construct
indic
luciferas
assay
mutat
site
almost
complet
rescu
knockdown
wild
type
wt
construct
figur
test
whether
transfect
mimic
could
target
endogen
hcmv
permiss
cell
compar
cell
transfect
nontarget
control
sirna
nc
mimic
protein
level
appreci
reduc
transfect
mimic
notabl
effici
almost
compar
commerci
sirna
figur
result
indic
effici
target
downregul
endogen
via
specif
locat
site
utr
sequenc
next
determin
effect
short
hairpin
rna
earli
innat
immun
respons
hcmv
stabli
transfect
hff
cell
construct
use
lentiviralbas
transduct
method
shown
figur
express
obvious
decreas
transduc
cell
compar
level
sicontrol
cell
observ
western
blot
analysi
confirm
knockdown
express
could
specif
reduc
activ
interferonrel
gene
downstream
gene
induc
hcmv
earli
infect
effect
similar
effect
sirna
studi
figur
importantli
activ
innat
immun
relat
gene
hcmv
infect
also
dramat
impair
sicontrol
group
cultur
medium
treat
cyclosporin
csa
cypa
specif
inhibitor
proven
block
interact
csa
appear
redund
role
inhibit
earli
innat
immun
respons
hcmv
infect
sinc
addit
csa
transduc
cell
group
effect
transcript
upregul
gene
taken
togeth
find
suggest
could
function
short
hairpin
rna
inhibit
earli
innat
immun
respons
hcmv
infect
support
import
interact
process
evalu
biolog
signific
hcmv
target
gener
mutant
hcmv
hcmv
bac
mutagenesi
prevent
potenti
artifact
result
full
sequenc
delet
mutant
construct
substitut
three
nucleotid
seed
sequenc
correspond
put
mrna
utr
target
site
figur
revert
viru
rvwt
construct
control
addit
construct
cell
line
stabli
overexpress
well
control
cell
line
effect
loss
function
interfer
express
infect
figur
rescu
downregul
rvwt
figur
sustain
overexpress
stablytransfect
cell
least
day
comparison
control
cell
figur
confirm
western
blot
analysi
next
examin
effect
ectop
express
rel
hcmvwt
wild
type
differ
phase
hcmv
replic
cycl
multistep
growth
singlestep
growth
curv
analyz
construct
cell
infect
rvwt
hcmvwt
low
moi
high
moi
respect
supernat
cellassoci
viru
harvest
togeth
dpi
indic
hcmv
titer
determin
viru
plaqu
assay
hff
cell
seen
figur
low
moi
multipl
replic
cycl
infect
measur
control
cell
hcmvwt
overexpress
cell
display
similar
slight
delay
viral
growth
statist
signific
ultim
reach
titer
plateau
hcmvwt
empti
vector
stablytransfect
cell
hcmv
wildtyp
revert
rvwt
show
similar
growth
kinet
reach
replic
plateau
almost
seven
day
postinfect
dpi
cell
howev
higher
moi
differ
viru
yield
observ
either
cell
infect
hcmv
mutant
viru
cell
overexpress
figur
similar
result
observ
mutant
wild
type
virus
use
infect
hff
cell
result
indic
hcmv
target
might
promot
cours
hcmv
lytic
propag
low
moi
numer
cell
surfac
glycoprotein
microglobulin
annexin
ii
plateletderiv
growth
factor
epitheli
growth
factor
receptor
egfr
integrin
suggest
act
receptor
facilit
hcmv
entri
howev
none
suggest
glycoprotein
valid
bona
fide
receptor
necessari
hcmv
infect
suscept
cell
type
vivo
broad
tissu
tropism
hcmv
infect
differ
permiss
differ
cell
type
suggest
hcmv
like
use
distinct
cell
surfac
receptor
depend
target
cell
thu
identifi
specif
hcmv
cellular
receptor
import
understand
pathogenesi
hcmv
transmembran
receptor
glycoprotein
belong
immunoglobulin
superfamili
express
vari
level
mani
tissu
cell
notabl
sever
bacteri
pathogen
neisseria
meningitidi
plasmodium
falciparum
well
mani
virus
includ
hbv
sarscov
measl
viru
mev
previous
found
infect
target
cell
via
indic
might
constitut
evolutionarili
conserv
pathogen
receptor
infect
spread
within
tissu
organ
unfortun
neither
infectionblock
experi
use
antibodi
viral
infect
test
cell
show
differ
facilit
hcmv
entri
figur
sinc
low
passag
clinic
hcmv
strain
use
experi
assum
function
broadspectrum
receptor
hcmv
infect
least
typic
vitro
permiss
cell
line
addit
pathogen
recognit
receptor
function
transmembran
receptor
protein
propos
mediat
signal
transduct
pathway
immedi
upon
pathogen
particl
attach
penetr
belong
type
membran
protein
candid
tumor
biomark
express
upregul
breast
cancer
tissu
lung
carcinoma
tissu
bladder
cancer
tissu
along
tumor
malign
invas
metastasi
extens
studi
sinc
discoveri
function
tumor
progress
metastasi
explor
previous
unknown
role
host
innat
immun
defens
hcmv
invas
cell
detect
hcmv
infect
earli
four
eight
hour
postinfect
hpi
respond
produc
cytokin
earli
peak
antivir
ifn
experi
indic
endogen
requir
maximum
activ
antivir
signal
trigger
hcmv
infect
possibl
redund
effect
cell
surfac
receptor
glycoprotein
figur
mani
tumorrel
protein
program
death
pten
known
play
key
role
regul
innat
immun
viral
bacteri
infect
howev
involv
earli
antivir
immun
appear
specif
hcmv
infect
sinc
extend
virus
like
sinc
signal
pathway
remain
well
defin
next
demonstr
phosphoryl
nuclear
transloc
might
play
lead
role
hcmvtrigger
antivir
signal
transduct
subsequ
activ
phosphoryl
orchestr
cytokin
plu
interferon
respons
figur
find
support
fact
key
transcript
enhancesomecompon
accord
previou
research
research
increasingli
suggest
modul
host
immun
microenviron
import
tumor
virusinduc
inflammatori
carcinogenesi
also
critic
persist
latent
viral
infect
exampl
viral
mimic
human
acquir
cellular
genom
bind
high
affin
human
receptor
limit
innat
adapt
immun
respons
even
effici
studi
demonstr
hcmv
infect
lead
express
secret
cellular
chemokin
cypa
studi
show
cypa
extracellular
ligand
receptor
secret
variou
cell
type
includ
vascular
smooth
muscl
cell
macrophag
fibroblast
trigger
cascad
inflammatori
respons
demonstr
hcmvtrigger
phosphoryl
activ
depend
releas
cypa
hcmv
infect
cell
interact
figur
although
hcmv
highli
speciesspecif
anim
model
yet
known
support
replic
specul
secret
extracellular
cypa
trigger
hcmv
infect
act
paracrin
mechan
stimul
uninfect
cell
defend
second
wave
infect
progeni
viru
interact
moreov
found
endogen
target
hcmvencod
utr
could
replac
sirna
mimic
inhibit
earli
innat
immun
respons
hcmv
infect
figur
mutat
hcmv
seed
sequenc
ectop
express
result
delay
multistep
growth
curv
low
moi
suggest
target
biolog
signific
figur
microrna
mirna
small
noncod
rna
molecul
gener
target
untransl
region
utr
mrna
sinc
discoveri
hcmvencod
mirna
least
matur
mirna
speci
encod
premirna
identifi
report
regul
multipl
aspect
viral
cellular
process
includ
viral
replic
immun
evas
format
virion
eukaryot
translat
matur
deriv
encod
hcmv
intergen
region
report
transcrib
upon
infect
highli
express
hpi
follow
gradual
increas
express
cours
hcmv
infect
one
might
expect
cell
would
respond
differ
infect
mutant
viru
late
time
hcmv
infect
express
level
obvious
downregul
howev
found
differ
express
isg
infect
mutant
viru
base
previou
studi
overal
find
reason
might
complex
late
stage
infect
hcmv
often
use
multifacet
redund
strategi
regul
immun
respons
thu
effect
natur
may
abl
detect
late
time
hcmv
infect
specul
secret
extracellular
cypa
trigger
hcmv
infect
act
primarili
defend
uninfect
cell
progeni
hcmv
viru
releas
neighbor
infect
cell
result
observ
lack
differ
viru
yield
higher
moi
irrespect
mutat
target
mrna
utr
ectop
express
understand
figur
summari
provid
first
evid
nonhcmv
receptor
glycoprotein
target
hcmvencod
may
tactic
acquir
hcmv
antagon
earli
innat
immun
respons
benefit
hcmv
chronic
infect
addit
hcmvinduc
paracrin
effect
hcmvinduc
express
cypa
could
caus
immun
microenviron
call
smolder
inflamm
could
potenti
contribut
develop
mani
hcmv
inflammatori
disord
